Elagolix Sodium

CAS 832720-36-2 21 current recordsSmall Molecule

Who holds supplier records for Elagolix Sodium? 21 organisations hold a current record for Elagolix Sodium: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (9), China (6), Taiwan (2), Spain (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Elagolix Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/elagolix-sodium

Reading the evidence

  • 21 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (21)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Elagolix Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India9China6Taiwan2Spain1Netherlands1Country not recorded for 2
Need Elagolix Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Elagolix Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL502182).

Chemical identity

IUPAC name
sodium 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
Canonical SMILES
CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+]
InChIKey
DQYGXRQUFSRDCH-UQIIZPHYSA-M
Synonyms
Elagolix sodium, Elagolix sodium component of oriahnn, Elagolix sodium salt, NBI-56418 NA, NBI-56418-NA, Orilissa, Orlissa, ORIAHNN COMPONENT ELAGOLIX SODIUM, RefChem:58961, NBI 56418Na, Elagolix sodium [USAN], Elagolix sodium (USAN)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Gonadotropin Releasing Hormone Receptor Antagonist
Mechanism of action
Cytochrome P450 2C19 Inhibitors; Cytochrome P450 3A Inducers; Gonadotropin Releasing Hormone Receptor Antagonists; P-Glycoprotein Inhibitors
Physiologic effect
Decreased GnRH Secretion

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Elagolix Sodium?

21 organisations hold an active US FDA Type II Drug Master File or a CEP for Elagolix Sodium: ALIVUS LIFE SCIENCES LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHANGZHOU PHARMACEUTICAL FACTORY (China), Chengda Pharmaceuticals Co., Ltd. (China), Dr. Reddy's Laboratories Ltd. (India), Formosa Laboratories, Inc. (Taiwan), Hetero Labs Limited (India) and LUPIN MANUFACTURING SOLUTIONS LTD, and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Elagolix Sodium Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 36633), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 36646), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 36738), Chengda Pharmaceuticals Co., Ltd. (DMF 37489), Dr. Reddy's Laboratories Ltd. (DMF 35473), Formosa Laboratories, Inc. (DMF 34907), Hetero Labs Limited (DMF 37037) and LUPIN MANUFACTURING SOLUTIONS LTD (DMF 36669) and 13 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Elagolix Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Elagolix Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.